Transaction #23537 · Form 4 · 0001213900-25-124063
CorMedix Inc. · Exercise / conversion · Common Stock
CorMedix Inc. · Transacted December 18, 2025 · Filed December 19, 2025
What does this filing report?
An SEC Form 4 filing for CorMedix Inc. records an exercise / conversion involving Common Stock on December 18, 2025. The reported quantity was 30,000. The filing date is December 19, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- CorMedix Inc.
- Company CIK
- 0001410098
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 30,000
- Reported price
- 4.43
- Reference value
- 132,900
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 539,496
- Ownership description
- Not reported
- SEC acceptance time
- Dec 19, 2025, 9:30 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Todisco Joseph ↗
Chief Executive Officer · Director
CIK 0001774807
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2
- These options were granted on 01/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.